Disease-associated mutations in CIAS1 induce cathepsin B-dependent rapid cell death of human THP-1 monocytic cells.
暂无分享,去创建一个
S. Adachi | T. Nakahata | T. Heike | J. Sagara | R. Nishikomori | T. Suda | Y. Miyachi | N. Kambe | N. Kanazawa | M. Saito | H. Tanizaki | A. Fujisawa
[1] F. Martinon,et al. Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.
[2] V. Dixit,et al. Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.
[3] S. Akira,et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3 , 2006, Nature.
[4] J. Ting,et al. Cryopyrin: in from the cold. , 2006, Immunity.
[5] T. Nakahata,et al. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome. , 2005, Arthritis and rheumatism.
[6] R. Nishikomori,et al. The cytosolic pattern-recognition receptor Nod2 and inflammatory granulomatous disorders. , 2005, Journal of dermatological science.
[7] M. Chamaillard,et al. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. , 2005, Annual review of biochemistry.
[8] N. Inohara,et al. ASC-mediated NF-κB Activation Leading to Interleukin-8 Production Requires Caspase-8 and Is Inhibited by CLARP* , 2005, Journal of Biological Chemistry.
[9] J. Castro,et al. Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] F. Martinon,et al. Identification of Bacterial Muramyl Dipeptide as Activator of the NALP3/Cryopyrin Inflammasome , 2004, Current Biology.
[11] A. Utani,et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. , 2004, Blood.
[12] F. Martinon,et al. Inflammatory Caspases Linking an Intracellular Innate Immune System to Autoinflammatory Diseases , 2004, Cell.
[13] G. Núñez,et al. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. , 2004, The Journal of biological chemistry.
[14] G. Gores,et al. Lysosomes in cell death , 2004, Oncogene.
[15] A. Fischer,et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. , 2004, Blood.
[16] F. Martinon,et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.
[17] P. Hawkins,et al. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. , 2004, Arthritis and rheumatism.
[18] Thomas Lengauer,et al. Disease-associated variants in PYPAF1 and NOD2 result in similar alterations of conserved sequence , 2003, Bioinform..
[19] Thomas Lengauer,et al. Structural localization of disease‐associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2 , 2003, FEBS letters.
[20] S. Foster,et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid , 2003, Nature Immunology.
[21] G. Kroemer,et al. Lysosomal Membrane Permeabilization Induces Cell Death in a Mitochondrion-dependent Fashion , 2003, The Journal of experimental medicine.
[22] G. Núñez,et al. Cell death and immunity: NODs: intracellular proteins involved in inflammation and apoptosis , 2003, Nature Reviews Immunology.
[23] Y. Ogura,et al. ASC is an activating adaptor for NF-κB and caspase-8-dependent apoptosis , 2003 .
[24] M. Chamaillard,et al. Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.
[25] Y. Ogura,et al. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. , 2003, Biochemical and biophysical research communications.
[26] S. Foster,et al. Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.
[27] D. Kastner,et al. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations , 2003, Current opinion in rheumatology.
[28] E. Remmers,et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. , 2002, Arthritis and rheumatism.
[29] Xiaoju Wang,et al. CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. , 2002, Arthritis and rheumatism.
[30] J. Bertin,et al. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF‐κB and caspase‐1 , 2002, FEBS letters.
[31] G. Hitman,et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. , 2002, Arthritis and rheumatism.
[32] F. Martinon,et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.
[33] A. Thatayatikom,et al. Mutation of a New Gene Encoding a Putative Pyrin-Like Protein Causes Familial Cold Autoinflammatory Syndrome and Muckle-Wells Syndrome , 2002, Pediatrics.
[34] A. Fischer,et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. , 2002, American journal of human genetics.
[35] K. Kågedal,et al. Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. , 2002, The American journal of pathology.
[36] S. Srinivasula,et al. The PYRIN-CARD Protein ASC Is an Activating Adaptor for Caspase-1* , 2002, The Journal of Biological Chemistry.
[37] D. Scott,et al. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. , 2002, American journal of human genetics.
[38] J. Bertin,et al. PYPAF1, a PYRIN-containing Apaf1-like Protein That Assembles with ASC and Regulates Activation of NF-κB* , 2002, The Journal of Biological Chemistry.
[39] G. Gores,et al. Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. , 2001, The American journal of pathology.
[40] Mingde Zhao,et al. Sphingosine-induced apoptosis is dependent on lysosomal proteases. , 2001, The Biochemical journal.
[41] Marcel Leist,et al. Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.
[42] Jonathan D. G. Jones,et al. Plant pathogens and integrated defence responses to infection , 2001, Nature.
[43] S. Martin,et al. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. , 2001, Trends in biochemical sciences.
[44] Marcel Leist,et al. Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis Factor , 2001, The Journal of cell biology.
[45] L. Ellerby,et al. Lysosomal Protease Pathways to Apoptosis , 2001, The Journal of Biological Chemistry.
[46] G. Gores,et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. , 2000, The Journal of clinical investigation.
[47] M. Hengartner. The biochemistry of apoptosis , 2000, Nature.
[48] Wei Li,et al. Induction of cell death by the lysosomotropic detergent MSDH , 2000, FEBS letters.
[49] P. Vandenabeele,et al. Non‐specific effects of methyl ketone peptide inhibitors of caspases , 1999, FEBS letters.
[50] W. Fiers,et al. Cathepsin B-mediated activation of the proinflammatory caspase-11. , 1998, Biochemical and biophysical research communications.
[51] Xiaodong Wang,et al. Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.
[52] Junying Yuan,et al. Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.
[53] K. Öllinger,et al. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. , 1998, The American journal of pathology.
[54] S. Orrenius,et al. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis , 1997, FEBS letters.
[55] J. Levinson,et al. Infantile multisystem inflammatory disease: a specific syndrome? , 1985, The Journal of pediatrics.
[56] J. Ting,et al. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. , 2005, Annual review of immunology.
[57] John Calvin Reed,et al. The PYRIN Connection: Novel Players in Innate Immunity and Inflammation , 2004 .
[58] S. Akira,et al. Toll-like receptors. , 2003, Annual review of immunology.
[59] Y. Ogura,et al. ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. , 2003, Biochemical and biophysical research communications.
[60] D. Kessel,et al. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage , 2002, Cell Death and Differentiation.
[61] E. Cadenas,et al. Apoptosis induced by exposure to a low steady-state concentration of H2O2 is a consequence of lysosomal rupture. , 2001, The Biochemical journal.
[62] 増本 純也. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells , 1999 .
[63] C. Griscelli,et al. A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. , 1987, Scandinavian journal of rheumatology. Supplement.